109 results
Page 2 of 6
6-K
EX-99.1
km05gzp3
10 Aug 22
Report of Foreign Private Issuer
9:05am
6-K
EX-99.1
870ee71iht6clqs wbv
8 Jun 22
BiondVax receives supportive Scientific Advice from the Paul Ehrlich
6:27am
6-K
EX-99.1
v9ck1r
3 Jun 22
BiondVax Announces First Quarter 2022 Financial Results and Provides Business Update
4:05pm
6-K
EX-99.2
h6a7yf2kfred5agnk
13 May 22
Report of Foreign Private Issuer
7:48am
6-K
EX-99.1
5379e0y
13 May 22
Report of Foreign Private Issuer
7:48am
6-K
EX-99.1
6mmn4
4 Apr 22
Report of Foreign Private Issuer
5:19pm
6-K
EX-99.1
f76ok0os
11 Jan 22
Report of Foreign Private Issuer
6:06am
6-K
EX-99.1
2va5kbsuax7v ltg65l
30 Dec 21
Former CFO of GSK’s Global Vaccines Business Mr. Jay Green Joins BiondVax’s Board of Directors
4:15pm
424B5
qbk5nps5l kbp9
28 Dec 21
Prospectus supplement for primary offering
5:20pm
424B5
ziroe
27 Dec 21
Prospectus supplement for primary offering
6:22am
6-K
EX-99.1
ndt1d59b
22 Dec 21
Report of Foreign Private Issuer
4:15pm
6-K
EX-99.1
x77i nlukkg1
13 Dec 21
Report of Foreign Private Issuer
7:34am
6-K
EX-99.1
ei3dbckugo0sg2q
2 Dec 21
BiondVax announces Third Quarter 2021 Financial Results and Provides Business Update
4:15pm
6-K
EX-99.1
7qaj85zbwccczflpvh
24 Nov 21
BiondVax Announces Notice of Annual General Meeting of Shareholders and Provides a Business Update
3:06pm
6-K
EX-99.1
tvejmgy0fqf8 q00k
25 Oct 21
BiondVax advances its growth strategy towards a new pipeline based on innovative VHH antibodies
6:04am
6-K
EX-99.1
q67kh7ects1z
26 Aug 21
BiondVax Announces Second Quarter 2021 Financial Results and Provides Business Update
4:32pm
6-K
EX-99.1
ed4fj dkxnjffz9oxt4u
23 Jun 21
BiondVax Announces First Quarter 2021 Financial Results and Provides Business Update
9:40am
6-K
EX-99.1
l4xuf306zgxozgippb2
13 May 21
BiondVax Announces Fourth Quarter and Full Year 2020 Financial Results
5:17pm